Benefit of chondroitinase ABC on sensory axon regeneration in a laceration model of spinal cord injury in the rat

Surgical Neurology

Volumn 69, Issue 6, 2008, Pages 568-577

  Shields, Lisa B E ^a   Zhang, Yi Ping ^a   Burke, Darlene A ^a   Gray, Rebecca ^a   Shields, Christopher B ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Axonal regeneration; Chondroitin sulfate proteoglycan; Chondroitinase; Extracellular matrix; Glial scar; Sensory axon; Spinal cord injury; Spinal cord laceration; Spinal cord regeneration; Vibraknife

Indexed keywords

CHONDROITIN ABC LYASE; GLIAL FIBRILLARY ACIDIC PROTEIN; LAMININ; PROTEOCHONDROITIN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GAIT; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOW DRUG DOSE; NERVE FIBER; NERVE REGENERATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SENSORY NERVE; SPINAL CORD INJURY;

ANIMALS; AXONS; CERVICAL VERTEBRAE; CHONDROITIN ABC LYASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, SPINAL; LACERATIONS; NERVE REGENERATION; NEURONS, AFFERENT; PROTEOCHONDROITIN SULFATES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES;

EID: 43449101472     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2008.02.009     Document Type: Article

References (65)

1. Bamber N.I., Li H., Lu X., et al. Neurotrophins BDNF and Nt-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci 13 (2001) 257-268
2. Bandtlow C., Zachleder T., and Schwab M.E. Oligodendrocytes arrest neurite growth by contact inhibition. J Neurosci 10 (1990) 3837-3848
3. Barritt A.W., Davies M., Marchand F., et al. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci 26 (2006) 10856-10867
4. Bradbury E.J., Khemani S., King V.R., et al. NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. Eur J Neurosci 11 (1999) 3873-3883
5. Bradbury E.J., Moon L.D., Popat R.J., et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416 (2002) 636-640
6. Bunge R.P., Puckett W.R., Becerra J.L., Marcillo A., and Quencer R.M. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 59 (1993) 75-89
7. Cafferty W.B.J., Yang S.H., Duffy P.J., et al. Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci 27 (2007) 2176-2185
8. Caterson B., Christner J.E., Baker J.R., et al. Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc 44 (1985) 386-393
9. Condic M.L., and Lemons M.L. Extracellular matrix in spinal cord regeneration: getting beyond attraction and inhibition. Neuroreport 13 (2002) A37-A48
10. David S., Braun P.E., Jackson D.L., et al. Laminin overrides the inhibitory effects of peripheral nervous system and central nervous system myelin-derived inhibitors of neurite growth. J Neurosci Res 42 (1995) 594-602
11. Davies S.J., Fitch M.T., Memberg S.P., et al. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390 (1997) 680-683
12. Davies S.J., Goucher D.R., Doller C., et al. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 19 (1999) 5810-5822
13. Domeniconi M., Cao Z., Spencer T., et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35 (2002) 283-290
14. Fawcett J.W., Fersht N., Housden L., et al. Axonal growth on astrocytes is not inhibited by oligodendrocytes. J Cell Sci 103 Pt 2 (1992) 571-579
15. Fidler P.S., Schuette K., Asher R.A., et al. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci 19 (1999) 8778-8788
16. Fitch M.T., and Silver J. Glial cell extracellular matrix: boundaries for axon growth in development and regeneration. Cell Tissue Res 290 (1997) 379-384
17. Fouad K., Dietz V., and Schwab M.E. Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors. Brain Res Brain Res Rev 36 (2001) 204-212
18. Fournier A.E., GrandPre T., Gould G., et al. Nogo and the Nogo-66 receptor. Prog Brain Res 137 (2002) 361-369
19. Fournier A.E., GrandPre T., and Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409 (2001) 341-346
20. Giger R.J., Cloutier J.F., Sahay A., et al. Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 25 (2000) 29-41
21. GrandPre T., Nakamura F., Vartanian T., et al. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 403 (2000) 439-444
22. Grimpe B., and Silver J. A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. J Neurosci 24 (2004) 1393-1397
23. Hays W. Statistics (1971), Holt, Rinehart, and Winston, New York
24. Houle J.D., Tom V.J., Mayes D., et al. Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci 26 (2006) 7405-7415
25. Huang W.C., Kuo W.C., Cherng J.H., et al. Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem Biophys Res Commun 349 (2006) 963-968
26. Huot J. Ephrin signaling in axon guidance. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 813-818
27. Inman D.M., and Steward O. Ascending sensory, but not other long-tract axons, regenerate into the connective tissue matrix that forms at the site of a spinal cord injury in mice. J Comp Neurol 462 (2003) 431-449
28. Jones L.L., Margolis R.U., and Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 182 (2003) 399-411
29. Jones L.L., Oudega M., Bunge M.B., et al. Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J Physiol 533 (2001) 83-89
30. Jones L.L., Sajed D., and Tuszynski M.H. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J Neurosci 23 (2003) 9276-9288
31. Jones L.L., and Tuszynski M.H. Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. J Neurosci 22 (2002) 4611-4624
32. Jones L.L., Yamaguchi Y., Stallcup W.B., et al. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 22 (2002) 2792-2803
33. Karim F., Volker D., and Schwab M.E. Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors. Brain Res Rev 36 (2001) 204-212
34. Kottis V., Thibault P., Mikol D., et al. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem 82 (2002) 1566-1569
35. Krautstrunk M., Scholtes F., Martin D., et al. Increased expression of the putative axon growth-repulsive extracellular matrix molecule, keratan sulphate proteoglycan, following traumatic injury of the adult rat spinal cord. Acta Neuropathol (Berl) 104 (2002) 592-600
36. Lemons M.L., Howland D.R., and Anderson D.K. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp Neurol 160 (1999) 51-65
37. Lemons M.L., Sandy J.D., Anderson D.K., et al. Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord. Exp Neurol 184 (2003) 981-990
38. Liu B.P., Fournier A., GrandPre T., et al. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297 (2002) 1190-1193
39. McKeon R.J., Hoke A., and Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 136 (1995) 32-43
40. McKeon R.J., Schreiber R.C., Rudge J.S., et al. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci 11 (1991) 3398-3411
41. McKerracher L., David S., Jackson D.L., et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13 (1994) 805-811
42. Moon L.D., Asher R.A., Rhodes K.E., et al. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat Neurosci 4 (2001) 465-466
43. Neumann S., and Woolf C.J. Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron 23 (1999) 83-91
44. Plant G.W., Bates M.L., and Bunge M.B. Inhibitory proteoglycan immunoreactivity is higher at the caudal than the rostral Schwann cell graft-transected spinal cord interface. Mol Cell Neurosci 17 (2001) 471-487
45. Properzi F., Asher R.A., and Fawcett J.W. Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury. Biochem Soc Trans 31 (2003) 335-336
46. Ramer M.S., Harper G.P., and Bradbury E.J. Progress in spinal cord research-a refined strategy for the International Spinal Research Trust. Spinal Cord 38 (2000) 449-472
47. Sandvig A., Berry M., Barrett L.B., et al. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 46 (2004) 225-251
48. Schmalfeldt M., Bandtlow C.E., Dours-Zimmermann M.T., et al. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 113 Pt 5 (2000) 807-816
49. Schwab M.E. Regenerative nerve fiber growth in the adult central nervous system. News Physiol Sci 13 (1998) 294-298
50. Silver J., and Miller J.H. Regeneration beyond the glial scar. Nat Rev Neurosci 5 (2004) 146-156
51. Sivasankaran R., Pei J., Wang K.C., et al. PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration. Nat Neurosci 7 (2004) 261-268
52. Spencer T., Domeniconi M., Cao Z., et al. New roles for old proteins in adult CNS axonal regeneration. Curr Opin Neurobiol 13 (2003) 133-139
53. Steinmetz M.P., Horn K.P., Tom V.J., et al. Chronic enhancement of the intrinsic growth capacity of sensory neurons combined with the degradation of inhibitory proteoglycans allows functional regeneration of sensory axons through the dorsal root entry zone in the mammalian spinal cord. J Neurosci 25 (2005) 8066-8076
54. Tang X., Davies J.E., and Davies S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 71 (2003) 427-444
55. Tropea D., Caleo M., and Maffei L. Synergistic effects of brain-derived neurotrophic factor and chondroitinase ABC on retinal fiber sprouting after denervation of the superior colliculus in adult rats. J Neurosci 23 (2003) 7034-7044
56. Vinson M., Strijbos P.J., Rowles A., et al. Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J Biol Chem 276 (2001) 20280-20285
57. Walsh F.S., and Doherty P. Cell adhesion molecules and neuronal regeneration. Curr Opin Cell Biol 8 (1996) 707-713
58. Wang K.C., Koprivica V., Kim J.A., et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417 (2002) 941-944
59. Wang X., Chun S.J., Treloar H., et al. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 22 (2002) 5505-5515
60. Weidner N., Grill R.J., and Tuszynski M.H. Elimination of basal lamina and the collagen "scar" after spinal cord injury fails to augment corticospinal tract regeneration. Exp Neurol 160 (1999) 40-50
61. Xu X.M., Zhang S.X., Li H., et al. Regrowth of axons into the distal spinal cord through a Schwann-cell-seeded mini-channel implanted into hemisected adult rat spinal cord. Eur J Neurosci 11 (1999) 1723-1740
62. Yamaguchi Y. Chondroitin sulfate proteoglycans in the nervous system. In: Iozzo R. (Ed). Proteoglycans: structure, biology, and molecular interactions (2000), Marcel Dekker, Inc, New York 379-402
63. Yang L., Jones N.R., Stoodley M.A., et al. Excitotoxic model of post-traumatic syringomyelia in the rat. Spine 26 (2001) 1842-1849
64. Zhang Y.P., Iannotti C., Shields L.B.E., et al. Dural closure, cord approximation, and clot removal: enhancement of tissue sparing in a novel laceration spinal cord injury model. J Neurosurg Spine 100 (2004) 343-352
65. Zuo J., Neubauer D., Dyess K., et al. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp Neurol 154 (1998) 654-662